Cargando…
NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis
BACKGROUND: At the beginning of tumorigenesis, newly born cancer cells must successfully avoid attack by the immune system. Although most abnormal cells are efficiently identified and destroyed by the immune system, particularly by NK cells, the molecular mechanisms by which newly born cancer cells...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796413/ https://www.ncbi.nlm.nih.gov/pubmed/31619256 http://dx.doi.org/10.1186/s13046-019-1429-z |
_version_ | 1783459581462052864 |
---|---|
author | Saga, Kotaro Park, Jinhee Nimura, Keisuke Kawamura, Norihiko Ishibashi, Airi Nonomura, Norio Kaneda, Yasufumi |
author_facet | Saga, Kotaro Park, Jinhee Nimura, Keisuke Kawamura, Norihiko Ishibashi, Airi Nonomura, Norio Kaneda, Yasufumi |
author_sort | Saga, Kotaro |
collection | PubMed |
description | BACKGROUND: At the beginning of tumorigenesis, newly born cancer cells must successfully avoid attack by the immune system. Although most abnormal cells are efficiently identified and destroyed by the immune system, particularly by NK cells, the molecular mechanisms by which newly born cancer cells evade NK cell surveillance are not fully understood. METHODS: NK cell resistance of highly tumorigenic population of human prostate cancer (PCa) cells were confirmed by xenograft in SCID mice with or without NK cell neutralization. The mechanisms by which the tumorigenic PCa cells evaded NK cell attack were investigated by RNAseq, ChIPseq, generation of several transformants and xenograft in SCID mice. RESULTS: Here, we show that PCa cells have a strengthened ability to escape NK cell attack due to NANOG, a pluripotent-related transcription factor, mediating the repression of ICAM1, a cell adhesion molecule, during tumorigenesis. Mechanistically, NANOG directly binds to the region upstream of ICAM1. As the binding between NANOG and the upstream ICAM1 region increases, p300 binding to this region is diminished, resulting in decreased ICAM1 expression. High NANOG expression confers PCa cells the ability to resist NK cell attack via the repression of ICAM1. Consistent with these results, low ICAM1 expression is significantly correlated with a high recurrence rate in patients with PCa. CONCLUSIONS: Our findings indicate that repression of ICAM1 is a critical mechanism by which cancer cells evade attack from NK cells during tumorigenesis. These results suggest a pivotal role of NANOG in establishing a gene expression profile for escaping the immune system. |
format | Online Article Text |
id | pubmed-6796413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67964132019-10-21 NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis Saga, Kotaro Park, Jinhee Nimura, Keisuke Kawamura, Norihiko Ishibashi, Airi Nonomura, Norio Kaneda, Yasufumi J Exp Clin Cancer Res Research BACKGROUND: At the beginning of tumorigenesis, newly born cancer cells must successfully avoid attack by the immune system. Although most abnormal cells are efficiently identified and destroyed by the immune system, particularly by NK cells, the molecular mechanisms by which newly born cancer cells evade NK cell surveillance are not fully understood. METHODS: NK cell resistance of highly tumorigenic population of human prostate cancer (PCa) cells were confirmed by xenograft in SCID mice with or without NK cell neutralization. The mechanisms by which the tumorigenic PCa cells evaded NK cell attack were investigated by RNAseq, ChIPseq, generation of several transformants and xenograft in SCID mice. RESULTS: Here, we show that PCa cells have a strengthened ability to escape NK cell attack due to NANOG, a pluripotent-related transcription factor, mediating the repression of ICAM1, a cell adhesion molecule, during tumorigenesis. Mechanistically, NANOG directly binds to the region upstream of ICAM1. As the binding between NANOG and the upstream ICAM1 region increases, p300 binding to this region is diminished, resulting in decreased ICAM1 expression. High NANOG expression confers PCa cells the ability to resist NK cell attack via the repression of ICAM1. Consistent with these results, low ICAM1 expression is significantly correlated with a high recurrence rate in patients with PCa. CONCLUSIONS: Our findings indicate that repression of ICAM1 is a critical mechanism by which cancer cells evade attack from NK cells during tumorigenesis. These results suggest a pivotal role of NANOG in establishing a gene expression profile for escaping the immune system. BioMed Central 2019-10-16 /pmc/articles/PMC6796413/ /pubmed/31619256 http://dx.doi.org/10.1186/s13046-019-1429-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Saga, Kotaro Park, Jinhee Nimura, Keisuke Kawamura, Norihiko Ishibashi, Airi Nonomura, Norio Kaneda, Yasufumi NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
title | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
title_full | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
title_fullStr | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
title_full_unstemmed | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
title_short | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
title_sort | nanog helps cancer cells escape nk cell attack by downregulating icam1 during tumorigenesis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796413/ https://www.ncbi.nlm.nih.gov/pubmed/31619256 http://dx.doi.org/10.1186/s13046-019-1429-z |
work_keys_str_mv | AT sagakotaro nanoghelpscancercellsescapenkcellattackbydownregulatingicam1duringtumorigenesis AT parkjinhee nanoghelpscancercellsescapenkcellattackbydownregulatingicam1duringtumorigenesis AT nimurakeisuke nanoghelpscancercellsescapenkcellattackbydownregulatingicam1duringtumorigenesis AT kawamuranorihiko nanoghelpscancercellsescapenkcellattackbydownregulatingicam1duringtumorigenesis AT ishibashiairi nanoghelpscancercellsescapenkcellattackbydownregulatingicam1duringtumorigenesis AT nonomuranorio nanoghelpscancercellsescapenkcellattackbydownregulatingicam1duringtumorigenesis AT kanedayasufumi nanoghelpscancercellsescapenkcellattackbydownregulatingicam1duringtumorigenesis |